Brucellosis. Bacterial infection, unspecified
Conditions
Interventions
In group A treatment is Doxycyclin(6w)+Rifampin(6w)+gentamycin(1w)
In group B treatment is Doxycyclin(6w)+Garlet(6w)+Gentamicin(1w)
Intervention 1: In group A treatment is Doxycyclin(6w)+Rifampin(6w)+gentamycin(1w). Intervention 2: In group B treatment is Doxycyclin(6w)+Garlet(6w)+Gentamicin(1w).
Treatment - Drugs
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with clinical symptoms of acute brucellosis;serologic test of wright at least 1:160 and 2ME of 1:40 exclusion criteria: age less than 8 years; the history of the two past years history of treatment of acute brucellosis; past history of chronic brucellosis; pregnant women; having inherent or acquired immunodeficiency; a history of sensitivity to garlic; Focale forms of brucellosis such as Spondylitis,endocarditis…
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical sign and symptoms. Timepoint: Days of 0,7,21,42. Method of measurement: physical exam and Questionair. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease of WBC , ESR , CRP. Timepoint: Days of 0,7,21,42. Method of measurement: Check of WBC,ESR,CRP.;Decrease of Serologic test. Timepoint: Days of 0,7,21,42. Method of measurement: Check of wright and 2ME. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhazaleh Akbarifard
Arak University of Medical Sciences
Outcome results
None listed